Skip to content
2000
Volume 16, Issue 19
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Although bioactivation is a well-documented process and the role of active metabolites in the drug discovery field has long been recognized, drug metabolites are usually ignored in virtual screening campaigns oriented to drug repositioning. The present article discusses different issues related to overlooking of the active metabolites in virtual screening campaigns, including an overview of the essential aspects of drug biotransformation and a summary of computational approaches that can provide solutions to those issues. Some valuable computational resources connected with this topic are also overviewed.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026616666160216155043
2016-08-01
2025-01-15
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026616666160216155043
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test